N

Nucleome Therapeutics

31 employees

Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Genetics

Date founded

2019

Funding rounds raised

Total raised

$42M

from 4 investors over 4 rounds

N

Nucleome Therapeutics raised $42M on October 19, 2022

Investors: Oxford Sciences Innovation, British Patient Capital and M Ventures

N

Nucleome Therapeutics raised undisclosed on June 2, 2020

Investors: Creative Destruction Lab

FAQ